Popular on EntSun
- EMBER™, the Only Standardized System Linking Workforce Identity to Growth, Appoints Global Brand Visionary Bret Sanford-Chung to Board of Directors - 1105
- $3 Billion Suicidal Depression Market Advancements on Multiple Fronts, Highlighted by FDA Fast Track Designation for Effective NRX 100 Drug Therapy - 1083
- Phinge®, Home of Netverse® and Netaverse™ With Verified and Safer AI Announces "Test the Waters" Campaign for Potential Regulation A+ Offering - 1052
- The 2025 "Aizu Festival" in Aizu Wakamatsu City will be held September 19–21 - 1032
- Ubleu Crypto Group Achieves FinCEN Registration and Colorado Incorporation, Accelerating U.S. Market Entry - 1026
- University Rankings Index Announces 2025 Rankings of the Top US Online Universities - 1000
- Perception meets learning: Museum of Illusions Orlando offers educational field trips - 981
- iPOP Alum Ava Jean lands role in the reboot of "Buffy the Vampire Slayer" - 934
- Titus Announces Triumphant Return to the Gospel Music Industry - 924
- Boston Industrial Solutions Launches Citrine® CAL-685 Silicone Primer - 853
Similar on EntSun
- CCHR: Involuntary Commitment Is Eugenics Repackaged as "Mental Health Care"
- Physician-Turned-Patient Launches Advocacy Campaign to Spotlight Disability Insurance Barriers
- Your Body Isn't Broken—It's Out of Balance: The New Book Revealing the Blueprint to Restore Hormone Balance, Sleep, Gut & Metabolic Health
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
- Counseling Center of New Smyrna Beach Expands Affordable Mental Health Services for Volusia County
- Albuquerque's Z-CoiL Footwear Brings All-American Family Business Story to Shark Tank Season Premiere
- NoviSign Sponsoring VARTECH 2025 - the B2B IT channel's #1 event
- CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
- $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
Dr. Jeff Gelblum Provides Alzheimer's Treatment to Patients in the US and Abroad
EntSun News/11032004
AVENTURA, Fla. - EntSun -- Dr. Jeff Gelblum, Neurologist at First Choice Neurology, has brought together clinical, imaging, and laboratory capabilities to provide rapid diagnosis and treatment to individuals suffering from Alzheimer's disease.
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on EntSun News
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on EntSun News
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on EntSun News
- 84 Ethiopian Churches Change Signboards to Shincheonji Church of Jesus
- BTXSGG Outlines Four-Pillar Framework to Enhance Digital Asset Security and Compliance
- NJTRX Positions for Next-Generation Asset Trading with U.S. Regulatory Framework
- Sci-Fi Author Don Viecelli Introduces Alien Times - Book 3, Retribution
- Freedom Flourishes in Dutch Capital on Destination: Scientology, Amsterdam
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on EntSun News
- Poncho Tha Popstar: The West's Next King
- Physician-Turned-Patient Launches Advocacy Campaign to Spotlight Disability Insurance Barriers
- Thorn Ridge® Creates a World of Legends & Lore
- Screenwriting Cruise Adds Howard Suber, Ph.D., to Inaugural 7-Day Screenwriting Lab at Sea
- Wacky Wednesday's Midweek Mayhem & Madness Ignites Delirious Comedy Club with Explosive Laughs!
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Source: First Choice Neurology
0 Comments
Latest on EntSun News
- iPOP Alum Madelaine Petsch Starring in Prime Video's "Maintenance Required"
- Counseling Center of New Smyrna Beach Expands Affordable Mental Health Services for Volusia County
- Marty the Martian Farmer: A Retro Sci-Fi Comedy with a Cosmic Twist
- Athena Forge (ATFG) Introduces Advanced Token for Technology-Driven Financial Ecosystem
- Albuquerque's Z-CoiL Footwear Brings All-American Family Business Story to Shark Tank Season Premiere
- NoviSign Sponsoring VARTECH 2025 - the B2B IT channel's #1 event
- Unicorp and BH Group Select Chasing Creative—Palm Coast Agency—to Lead Growth Marketing for The Ritz-Carlton Residences, Hammock Dunes
- Angelique Bates Presents: All That & A Bag of Jokes
- Basketball Meets Innovation: THE LEAGUE's Culture-Driven Platform
- Breaking: 50+ runners from 20+ states relay custom 9/11 flag 485 miles from Shanksville through DC to Ground Zero for memorial remembrance run
- SecureMaine 2025 is this October 8th in Portland, Maine
- Celebrity Psychic Jesse Bravo Brings New York's Premier Psychic to Global Audiences New York, NY
- John Thomas calls for unity and prayer after tragic loss
- From Page to Premiere: The Golden State Signature Series: A DonnaInk Publications Signature Showcase
- Where the Miami Dolphins Stand After Week 1
- Which NFL Teams Can Rebound from Week 1? OddsTrader Breaks Down the Biggest Questions
- Barry J. Neely's The Demon Detective Original Score to be Released
- iPOP Alum Pierson Fode starring in Netflix's 'The Wrong Paris"
- Genesis Creations Entertainment expanding into Soul Purpose Reports
- Apellix Deploys Breakthrough Spray-Painting Drones into Live Service Limited Beta Program Open for Advanced Contractors